XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Other Financial Information (Tables)
 3 Months Ended
Apr. 02, 2023
Other Financial Information [Abstract]  
Schedule of Components of Inventories, Current
The following summarizes the components of Inventories:
(MILLIONS)April 2,
2023		December 31, 2022
Finished goods$2,657 $2,603 
Work-in-process6,129 5,519 
Raw materials and supplies755 859 
Inventories(a)
$9,541 $8,981 
Noncurrent inventories not included above(b)
$5,616 $5,827 
(a)The increase from December 31, 2022 reflects higher inventory levels for Paxlovid and increases for certain products due to supply recovery and inventory build, partially offset by decreases due to market demand.
(b)Included in Other noncurrent assets. Based on our current estimates and assumptions, there are no recoverability issues for these amounts, which are primarily related to Paxlovid.
Schedule of Components of Inventories, Noncurrent
The following summarizes the components of Inventories:
(MILLIONS)April 2,
2023		December 31, 2022
Finished goods$2,657 $2,603 
Work-in-process6,129 5,519 
Raw materials and supplies755 859 
Inventories(a)
$9,541 $8,981 
Noncurrent inventories not included above(b)
$5,616 $5,827 
(a)The increase from December 31, 2022 reflects higher inventory levels for Paxlovid and increases for certain products due to supply recovery and inventory build, partially offset by decreases due to market demand.
(b)Included in Other noncurrent assets. Based on our current estimates and assumptions, there are no recoverability issues for these amounts, which are primarily related to Paxlovid.